Principaux concurrents
Rendement du dividende (Y) Rendement du dividende (Y+1) PER (Y) Price to Book (Y) VE / CA (Y) VE / EBITDA (Y) VE / EBIT (Y) Capi.($)
0,58 %0,66 %17.51x2.02x3.84x10.32x11.38x 67,44 Md
0,58 %0,59 %27.36x4.11x5.63x16.53x20.89x 53,98 Md
-.--%-.--%35.27x7.08x11.95x22.64x26.61x 41,77 Md
3,32 %3,4 %-46.27x2.52x3.25x9.6x11.21x 41,15 Md
-.--%-.--%-9.21x5.42x13.41x-8.22x-7.77x 29,28 Md
-.--%-.--%31.34x1.61x3.56x11.02x12.92x 29,58 Md
-.--%-.--%17.13x3.43x3.29x9.96x9.78x 23,43 Md
-.--%0,05 %56.27x5.53x6.08x42.2x39.03x 19,11 Md
-.--%-.--%26.8x3.75x5.49x14.74x20.37x 16,82 Md
-.--%-.--%-35.54x-6.21x16.63x-50.5x-52.95x 15,36 Md
-.--%-.--%-125.69x13228.81x12.92x-114.56x-127.57x 12,64 Md
0,15 %0,16 %61.75x25.18x37.5x53.04x54.7x 11,12 Md
-.--%-.--%17.13x - 3.64x13.33x15.98x 11,55 Md
-.--%-.--%47.81x - - - - 11,07 Md
2,82 %3,26 %11.89x1.04x1.81x7.29x9.77x 6,19 Md
1,55 %1,72 %14.54x1.34x2.59x6.7x8.11x 5,65 Md
0,37 %0,43 %28.21x - 7.57x20.1x24x 5,5 Md
Moyenne 0,55 % 0,6 % 10,37x 948,97x 8,70x 4,01x 4,78x 23,62 Md
Moyenne pondérée par Capi. 0,59 % 0,63 % 10,96x 451,37x 7,49x 7,72x 9,08x
Biopharmacies
🔇